Call for abstracts
Submit your abstract
We are pleased to invite you to submit your abstract to The International Symposium on Sjögren's Disease 2026. Abstracts must be submitted exclusively via the online platform available from after reading the instructions below.
- Call for abstracts opening date - January 5th, 2026
- Abstract submission deadline - May 4th, 2026
- Notification of acceptance to authors (oral, poster) - Late june, 2026
- Conference Dates - September 29th – October 2nd, 2026
The person submitting the abstract needs first to identify the presenting author who must be registered to the congress just after notification, in order to present his/her abstract.
As the primary contact for the abstract, the presenting author will be responsible for:
- communicating to all co-authors regarding the acceptance of the abstract.
- obtaining conflict of interest disclosures from them.
Please respect the following instructions for the preparation of your abstract:
Your abstract must not exceed 500 words.
Up to two figures, tables, or other graphical elements may be included in your abstract submission.
Abstracts may be submitted in two categories: Physicians or Patients, depending on the profile of the main author and the focus of the work presented.
All abstracts will be considered. They will be selected by the Scientific Committee for presentation or poster form.
You need to select the topics of your abstract. There are 6 topics:
- Patients perspectives
- New diagnostic tools
- Pathogenic aspects
- Clinical aspects
- Treatments
- Clinical trials
There is no limit on the number of abstracts that may be submitted by any author.
Following sections are required:
- Background
- Aim
- Methods
- Results
- Discussions / Conclusion
All presentations will be accepted based on quality, relevance and space availability after review by the Scientific Program Committee.
Upon acceptance, the ISSjD Organizing Committee reserves the right to publish the submitted abstracts in the congress proceedings, website, or other related materials. Submission implies consent for such use without additional approval from the author(s).
For any questions regarding your submission, please do not hesitate to contact the Scientific Secretariat: